Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Solid Tumor, Adult × PankoMab-GEX × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1 Solid Tumor, Adult 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

pembrolizumab 5 Proton Therapy 3 spartalizumab 2 Paclitaxel 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 toripalimab 1 sotorasib 1 peposertib 1 necitumumab 1 leronlimab 1 abemaciclib 1 Valganciclovir 1 Trastuzumab 1 Therapeutics 1 Radiotherapy 1 PankoMab-GEX 1 Panitumumab 1 MEK inhibitor I 1 Jupiter 1 Ipilimumab 1 Interleukin-2 1 GAT 1 Fulvestrant 1 FCN-437c 1 EBI-005 1 Docetaxel 1 Catalytic Domain 1 Carboplatin 1 CS-1003 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡